Join our LinkedIn PATENTSCOPE users Community Group
Feedback
Settings

Settings

Goto Application

3,109 results
Offices all Languages Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61L2/00 AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 311
1.4186563CORONA VIRUS KILLING AGENT
EP - 31.05.2023
Int.Class A61P 31/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
02Local antiseptics
 Appl.No 21846163 Applicant SANKEI CO LTD Inventor GODA HISATAKA
The present disclosure provides a corona virus killing agent. In particular, the present disclosure provides a corona virus killing agent containing chlorous acid water. In particular, the present disclosure provides a method for killing corona virus, using chlorous acid water. The free chlorine concentration of the chlorous acid water (as Cl = 35.45) may be at least 5 ppm or greater in the absence of organic matter. The content of chlorous acid in the chlorous acid water (as HClO2 = 68.46) may be at least 200 ppm or greater in the presence of organic matter such as when disinfecting hands/fingers. The corona virus may be SARS corona virus (SARS-CoV), MERS corona virus (MERS-CoV), or the 2019 novel corona virus (SARS-CoV-2).
2.2602308Use of a composition as a viricide
GB - 29.06.2022
Int.Class A01N 65/06
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
65Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
06Coniferophyta , e.g. cypress
 Appl.No 202020438 Applicant HANKKIJA OY Inventor JOHN MCGRATH
The use of a composition comprising rosin as a viricide. Also provided is the use of a composition comprising rosin as a disinfectant, and a method for deactivating or destruction of a virus, comprising contacting the virus with a composition comprising rosin. The composition may comprise at least one of wood rosin, soft wood rosin, gum rosin, tall oil rosin, distilled tall oil, and tall oil fatty acid. The composition may comprise a sodium or potassium soap of rosin. The composition preferably comprises about 2% w/w rosin. The composition may comprise at least one resin acid selected from abietic acid, neoabietic acid, dehydroabietic acid, palustric acid, levopimaric acid, pimaric acid, and isopimaric acid. The composition may comprise 25% w/w alcohol, a mono- or polyhydric alcohol, an alicyclic alcohol, an alcohol ester, or a combination thereof. The composition may be greater than 2.5% w/w solution. The virus may be an enveloped virus, which may be a coronaviridae virus (corona virus), and may be the strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
3.1020220002142PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CORONAVIRUS INFECTION COMPRISING NANO-SIZED GRAPHENE OXIDE COMPOSITE AND METHOD USING SAME
KR - 06.01.2022
Int.Class A61K 33/44
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
44Elemental carbon, e.g. charcoal, carbon black
 Appl.No 1020210084753 Applicant 주식회사 바이오고 Inventor KANG KYUNG SUN
Provided are: a pharmaceutical composition for preventing or treating coronavirus infection or infectious diseases; a disinfecting composition; a composition for a health functional food or feed; and a method using the compositions, wherein the compositions comprise a nano-sized graphene oxide composite. The nano-sized graphene oxide has anti-coronavirus activity, and thus can be used for the prevention or treatment of coronavirus infection or the disinfection of coronaviruses. COPYRIGHT KIPO 2022
4.2021256083Methods of diagnosing and treating viral infections
AU - 21.10.2021
Int.Class A61H 33/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
33Bathing devices for special therapeutic or hygienic purposes
 Appl.No 2021256083 Applicant Almishari, Ibrahim Saud Inventor ALMISHARI, Ibrahim Saud
Diagnosing and treating viral infections. One example is a method of diagnosing absence of severe acute respiratory syndrome 2 (SARS-CoV-2), the method including: isolating a human in a covid-free environment for an isolation period; performing measurements of a core temperature during the isolation period; and if each of the measurements of the core temperature indicate a lack of fever, declaring the human free of SARS-CoV-2. Another example is a method including treating coronavirus in a human by: receiving a core temperature measurement; receiving a test result regarding the SARS-CoV-2 virus; responsive to the human having both fever and the presence of the SARS-CoV-2 virus, submerging the trunk and the legs of the human in water with a surfactant, and the human at least partially submerged for a treatment period of at least three hours; and controlling a temperature of the water during the treatment period.
5.WO/2021/209810METHODS OF DIAGNOSING AND TREATING VIRAL INFECTIONS
WO - 21.10.2021
Int.Class A61H 33/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
33Bathing devices for special therapeutic or hygienic purposes
 Appl.No PCT/IB2021/000239 Applicant ALMISHARI, Ibrahim, Saud Inventor ALMISHARI, Ibrahim, Saud
Diagnosing and treating viral infections. One example is a method of diagnosing absence of severe acute respiratory syndrome 2 (SARS-CoV-2), the method including: isolating a human in a covid-free environment for an isolation period; performing measurements of a core temperature during the isolation period; and if each of the measurements of the core temperature indicate a lack of fever, declaring the human free of SARS-CoV-2. Another example is a method including treating coronavirus in a human by: receiving a core temperature measurement; receiving a test result regarding the SARS-CoV-2 virus; responsive to the human having both fever and the presence of the SARS-CoV-2 virus, submerging the trunk and the legs of the human in water with a surfactant, and the human at least partially submerged for a treatment period of at least three hours; and controlling a temperature of the water during the treatment period.
6.WO/2022/016006PHOTOCATALYTIC AND PHOTO(ELECTRO)CATALYTIC APPROACHES FOR VIRAL DECONTAMINATION
WO - 20.01.2022
Int.Class A61L 2/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
2Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
02using physical phenomena
08Radiation
10Ultra-violet radiation
 Appl.No PCT/US2021/041873 Applicant NEVADA RESEARCH & INNOVATION CORPORATION Inventor SUBRAMANIAN, Vaidyanathan
Disclosed herein are systems and methods for decontaminating surfaces from human coronaviruses, such as SARS coronavirus 2 (SARS-CoV-2), and structures for decontamination from human coronaviruses. A structure for decontamination includes a first surface and a decontamination layer on the first surface. The decontamination layer comprises a nanostructured photocatalyst. Human coronaviruses on the decontamination layer are exposed to UV radiation and/or visible light. After the exposure, the human coronaviruses on the decontamination layer are inactivated. In some embodiments, the decontamination layer can include additives and/or an electrical bias can be applied to further reduce the exposure time required for viral inactivation.
7.2008201523Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases
AU - 24.04.2008
Int.Class C07K 14/155
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
155Lentiviridae, e.g. human immunodeficiency virus (HIV), visna-maedi virus, equine infectious anaemia virus
 Appl.No 2008201523 Applicant Eli Lilly and Company Inventor Bellotti, Marc
The present invention relates to a method for reducing the occurrence and severity of infectious diseases, especially infectious diseases in which lipid-containing infectious viral organisms are found in biological fluids, such as blood. The present invention employs solvents useful for extracting lipids from the lipid-containing infectious viral organism thereby creating modified viral particles with reduced infectivity and enhanced antigenicity. The present invention provides for the use of these modified viral particles in the preparation of medicaments for prevention and/or treatment of one or more viral diseases in a patient. The present invention provides vaccine compositions, comprising these modified viral particles with reduced infectivity and enhanced antigenicity, optionally combined with a pharmaceutically acceptable carrier or an immunostimulant. The vaccine composition is administered to a patient to provide protection against the lipid-containing infectious viral organism. The vaccine composition of the present invention include combination vaccines of modified viral particles obtained from one or more strains of a virus and/or one or more types of virus.
8.WO/2021/226232AERIAL DISINFECTION
WO - 11.11.2021
Int.Class A61L 9/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
9Disinfection, sterilisation or deodorisation of air
14using sprayed or atomised substances
 Appl.No PCT/US2021/030881 Applicant GRIGNARD PURE LLC Inventor GRIGNARD III, Emile Etienne
This disclosure relates to a method for disinfecting a space. The method includes spraying a composition containing triethylene glycol into a space containing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an amount effective to inactivate SARS-CoV-2.
9.WO/2021/245422METAL ORGANIC FRAMEWORK BASED PHOTOCATALYTIC SYSTEM
WO - 09.12.2021
Int.Class A61L 2/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
2Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
 Appl.No PCT/GB2021/051389 Applicant FRAMERGY INC. Inventor ORNSTEIN, Jason
The invention provides a system for destroying contagious and infectious, airborne micro-organisms such as bacteria, staphylococcus, hepatitis, virus and other harmful, viable organisms that may be present in the air. Additionally or alternatively, the system may be employed to remove and/or destroy poisonous gases. The system comprises an air inlet, an air outlet, a surface located between the air inlet and the air outlet, and a light source configured to project light onto said surface; said surface having a coating that comprises a metal organic framework.
10.20230034357Aerial Disinfection
US - 02.02.2023
Int.Class A01N 31/02
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
31Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
02Acyclic compounds
 Appl.No 17933365 Applicant Grignard Pure LLC Inventor Emile Etienne Grignard, III

This disclosure relates to a method for disinfecting a space. The method includes spraying a composition containing triethylene glycol into a space containing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an amount effective to inactivate SARS-CoV-2.

# -